NO863082D0 - PREPARATION FOR INTRAMUSCULAR INJECTION OF PHARMACEUTICALS, VITAMINS OR VACCINES. - Google Patents

PREPARATION FOR INTRAMUSCULAR INJECTION OF PHARMACEUTICALS, VITAMINS OR VACCINES.

Info

Publication number
NO863082D0
NO863082D0 NO1986863082A NO863082A NO863082D0 NO 863082 D0 NO863082 D0 NO 863082D0 NO 1986863082 A NO1986863082 A NO 1986863082A NO 863082 A NO863082 A NO 863082A NO 863082 D0 NO863082 D0 NO 863082D0
Authority
NO
Norway
Prior art keywords
intramuscular injection
vaccines
vitamins
pharmaceuticals
preparation
Prior art date
Application number
NO1986863082A
Other languages
Norwegian (no)
Other versions
NO863082L (en
Inventor
Faruk Hadziselimovic
Original Assignee
Mepha Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mepha Ag filed Critical Mepha Ag
Publication of NO863082L publication Critical patent/NO863082L/en
Publication of NO863082D0 publication Critical patent/NO863082D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

The addition of pharmaceutically accepted hydrosoluble organic or inorganic calcium salts, particularly calcium glucoheptonate to a drug, vitamin or vaccine to be administered by intramuscular injection enables to obtain a painless injection without adding local anaesthetics.
NO1986863082A 1984-12-07 1986-07-30 PREPARATION FOR INTRAMUSCULAR INJECTION OF PHARMACEUTICALS, VITAMINS OR VACCINES. NO863082D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH586084 1984-12-07
PCT/CH1985/000172 WO1986003413A1 (en) 1984-12-07 1985-12-06 Preparations for the intramuscular injection of drugs, vitamins or vaccines

Publications (2)

Publication Number Publication Date
NO863082L NO863082L (en) 1986-07-30
NO863082D0 true NO863082D0 (en) 1986-07-30

Family

ID=4300514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1986863082A NO863082D0 (en) 1984-12-07 1986-07-30 PREPARATION FOR INTRAMUSCULAR INJECTION OF PHARMACEUTICALS, VITAMINS OR VACCINES.

Country Status (9)

Country Link
EP (1) EP0204737B1 (en)
KR (1) KR870700024A (en)
AT (1) ATE74523T1 (en)
AU (1) AU5198686A (en)
DE (1) DE3585835D1 (en)
DK (1) DK365786D0 (en)
FI (1) FI863192A (en)
NO (1) NO863082D0 (en)
WO (1) WO1986003413A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
NO20014746D0 (en) 2001-09-28 2001-09-28 Clas M Kjoelberg Pain reliever
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
WO2006012700A1 (en) * 2004-08-04 2006-02-09 Team Health Pty Ltd Method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1023821A (en) * 1950-04-21 1953-03-24 Stable solution of calcium gluconate and process for its preparation
DE1007022B (en) * 1953-06-02 1957-04-25 Sandoz Ag Process for improving the shelf life and solubility of antihistamine preparations
DE1062389B (en) * 1958-02-11 1959-07-30 Wander Ag Dr A Process for the preparation of sterile vitamin D solutions containing calcium salts
US4081527A (en) * 1976-12-07 1978-03-28 Pfizer Inc. Chlortetracycline compositions

Also Published As

Publication number Publication date
AU5198686A (en) 1986-07-01
WO1986003413A1 (en) 1986-06-19
FI863192A0 (en) 1986-08-05
FI863192A (en) 1986-08-05
KR870700024A (en) 1987-02-28
EP0204737B1 (en) 1992-04-08
ATE74523T1 (en) 1992-04-15
DK365786A (en) 1986-07-31
DK365786D0 (en) 1986-07-31
EP0204737A1 (en) 1986-12-17
NO863082L (en) 1986-07-30
DE3585835D1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
ES2061799T3 (en) NEW MEDICATION PREPARATION AND PROCEDURE FOR ITS PREPARATION.
ES2061094T3 (en) A PROCEDURE FOR OBTAINING A FORMULATION TO DECREASE THE IMPERIOUS DESIRE OF ALCOHOL (CRAVING) IN THE TREATMENT OF CHRONIC ALCOHOLISM.
NO174412C (en) Process for preparing a programmed release pharmaceutical formulation for oral use
NO863620L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
ES2074124T3 (en) COMPOSITION IN THE FORM OF A FOAM CONTAINING 5-AMINOSALICYLIC ACID FOR INTRA-RECTAL ADMINISTRATION.
ES2052717T3 (en) USE OF INDOLONE DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF PARKINSON'S DISEASE.
FI935844A (en) EN DOSERINGSFORM FOER FOERDROEJD BEFRIANDE AV ETT CEILING MODEL
PT90049A (en) DOSAGE FORM FOR ADMINISTERING A HUMAN THERAPY MEDICINE
PT88138A (en) METHOD FOR PRODUCING A METHOD OF ADMINISTRATION OR DOSAGE FOR ACTIVE MEDICINAL SUBSTANCES THROUGH A PRINTING PROCESS
ES2059312T3 (en) MEDICATION THAT CAN BE ADMINISTERED BY THE NASAL VIA, PROCEDURE FOR ITS PREPARATION AND ITS APPLICATION.
SE8002715L (en) INJECTABLE MEDICINAL PRODUCTS WITH INFLAMMATION DISABILITY EFFECT AND SET FOR PREPARATION THEREOF
NO863082D0 (en) PREPARATION FOR INTRAMUSCULAR INJECTION OF PHARMACEUTICALS, VITAMINS OR VACCINES.
DE3786304T2 (en) Immunostimulating drugs.
KR910005858A (en) Fatty acid therapy
IT1241079B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
ES2043943T3 (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH CENTRAL ANALGESIC ACTIVITY.
ATE48993T1 (en) AETHEROXIDE DERIVATIVES OF CYCLOPROPYLPHENOLS.
SE8501312L (en) ORAL DOSAGE FORM FOR ETOPSIDE
SE7708622L (en) 2-BENZYL-PERHYDROAZEPINES, PREPARATIONS AND MEDICINAL PRODUCTS, CONTAINING THEM
DK400887D0 (en) USE OF 15-DEOXYSPERGUALIN FOR THE PREPARATION OF A MEDICINAL PRODUCT
ES2032476T3 (en) A PROCEDURE FOR PREPARING NEW 2-ANILINOTIAZOLINE DERIVATIVES.
DE3689254D1 (en) Dextrorphan-based drugs for intranasal application.
ES2052475T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF IMMUNOORGANIC DISORDERS INCLUDING PP14 OR ANTIBODIES PP14.
SE8105500L (en) PSYCHOTROPA MEDICINAL PRODUCTS
AR029415A1 (en) PIRROLES REPLACED, A PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES